Long-term complete radiological response to immunotherapy in a patient with metastatic NSCLC and active rheumatoid arthritis
{{output}}
The use of immune checkpoint inhibitors (ICIs) in patients with autoimmune diseases (AIDs) is challenging due to the risk of immune-related adverse events and disease flares. These patients are routinely excluded from clinical trials, leaving limited evidence ... ...
